Ready to support smoother, firmer, and more resilient skin at a deeper level
HTD1801 has been evaluated in multiple clinical studies including a Phase 2, placebo-controlled study of type 2 diabetes mellitus (T2DM) in Chinese patients (Study 1) and a Phase 2, placebo-controlled study of presumed metabolic dysfunction-associated steatohepatitis (MASH) and T2DM in predominantly western patients (Study 2)
Each dose level usually lasts 4 weeks before the next increase
Please avoid obscene, vulgar, lewd, racist or sexually-oriented language
Effect of renal impairment on the pharmacokinetics, efficacy, and safety of albiglutide
If you suspect a storage breach, the safest approach is to obtain a fresh supply from your pharmacy rather than risk injecting compromised medication